Literature DB >> 12691458

Hepatitis C virus genetic variability: pathogenic and clinical implications.

Jean-Michel Pawlotsky1.   

Abstract

HCV is variable because of the properties of the viral RdRp, high levels of replication, and large population sizes. The Darwinian evolution of HCV has been characterized by the emergence of the HCV genotypes, including six main types and a large number of subtypes. The study of HCV genotype epidemiology provides useful information on the worldwide HCV epidemics. The HCV genotype is an important predictor of the response to IFN-alpha-based antiviral therapy, and genotype determination is currently used to tailor treatment indications. In addition, HCV circulates and behaves in infected individuals as mixtures of closely related but distinct viral populations referred to as quasispecies. This particular nature of the virus influences its transmission, the pathogenesis of liver disease and extra-hepatic manifestations, and the outcome during and after antiviral therapy or after transplantation for HCV-related end-stage liver disease. Further studies are needed to understand better the implications of HCV quasispecies diversity in the pathophysiology of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691458     DOI: 10.1016/s1089-3261(02)00065-x

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  46 in total

Review 1.  Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.

Authors:  Maya Gambarin-Gelwan; Ira M Jacobson
Journal:  Curr Gastroenterol Rep       Date:  2012-02

2.  Therapeutic implications of hepatitis C virus resistance to antiviral drugs.

Authors:  Jean-Michel Pawlotsky
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

3.  Predicting the probable outcome of treatment in HCV patients.

Authors:  Udayakumar Navaneethan; Nyingi Kemmer; Guy W Neff
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

Review 4.  Viral hepatitis in HIV infection.

Authors:  Margaret James Koziel; Marion G Peters
Journal:  N Engl J Med       Date:  2007-04-05       Impact factor: 91.245

5.  Dynamics of hepatitis B virus resistance to lamivudine.

Authors:  Coralie Pallier; Laurent Castéra; Alexandre Soulier; Christophe Hézode; Patrice Nordmann; Daniel Dhumeaux; Jean-Michel Pawlotsky
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Hepatitis C hypervariable region 1: association of reduced selection pressure in african americans with treatment failure.

Authors:  Vicki M Park; Barbara C Mason; Julia Krushkal; Rongling Li; Caroline Riely; Jaquelyn Fleckenstein
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

7.  Evolution of Newcastle Disease Virus Quasispecies Diversity and Enhanced Virulence after Passage through Chicken Air Sacs.

Authors:  Chunchun Meng; Xusheng Qiu; Shengqing Yu; Chuanfeng Li; Yingjie Sun; Zongyan Chen; Kaichun Liu; Xiangle Zhang; Lei Tan; Cuiping Song; Guangqing Liu; Chan Ding
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

8.  Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

Authors:  Hurng-Yi Wang; Ming-Hung Chien; Hsiang-Po Huang; Hsiao-Chi Chang; Chung-Che Wu; Pei-Jer Chen; Mei-Hwei Chang; Ding-Shinn Chen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 10.  Managing chronic hepatitis C in the difficult-to-treat patient.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Liver Int       Date:  2007-12       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.